Pharmafile Logo
Pharmafocus logo
Advanced Search
Vaccination

Cheaper vaccines for developing countries

March 24, 2010
Vaccine, developing world, vaccines

GlaxoSmithKline and Pfizer have signed a deal to supply anti-pneumococcal drugs to developing countries at steeply discounted prices. GSK will …

News
QuintilesGeoffOwen

Quintiles hands Geoff Owen global business development role

March 24, 2010
Sales and Marketing Quintiles, appointment, sales and marketing

Contract services company Quintiles has appointed Geoff Owen to lead global business development for its Commercial group. As senior vice …

Appointment

Adverse event halts Merck cancer vaccine trial

March 23, 2010
Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …

News

Virus contamination found in GSK’s Rotarix

March 23, 2010
Business Services, Manufacturing and Production, Sales and Marketing Contamination, GSK, Vaccine, manufacturing compliance

The European Medicines Agency has demanded more information “as a matter of urgency” from GlaxoSmithKline over a virus in its …

News
Blog footer

Digital Pharma: The industry’s real social media question

March 23, 2010
Medical Communications Janssen, digital pharma, social media

There is a tremendous amount of discussion at the moment about how trust is now the key to corporate reputation. …

Feature

Emma Walmsley to head up GSK consumer healthcare

March 23, 2010
Sales and Marketing GlaxoSmithKline, appointment, consumer healthcare, sales and marketing

GlaxoSmithKline has appointed Emma Walmsley president, Consumer Healthcare Europe and president designate, Worldwide Consumer Healthcare with effect from 1 May. …

Appointment

PPD boosts position in flu vaccine research

March 23, 2010
Research and Development CRO, PPD, Southern Research Institute, vaccines

PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …

News

US House passes health reform

March 22, 2010
Sales and Marketing Obama, US healthcare

The US House of Representatives has passed an historic bill which represents a major reform for America’s healthcare system. Passed …

News

CHMP in brief: Hospira’s Nivestim approved

March 22, 2010
Research and Development EMA

A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …

News

Tarceva gets nod for maintenance treatment

March 22, 2010
Sales and Marketing Tarceva, lung cancer

Tarceva looks set to gain approval in Europe to treat patients with non-small cell lung cancer whose disease remains stable …

News

The health crunch: can the NHS flourish in leaner times?

March 22, 2010
NHS, NHS funding, qof

The economic downturn which hit the UK in 2009 coincided with a pre-planned slowing down in the investment in the …

Feature

Pfizer’s Kindler elected PhRMA chairman

March 22, 2010
Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing

Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …

Appointment

Merck joins coalition for biosecurity vaccine plant

March 22, 2010
Manufacturing and Production, Research and Development biodefence, vaccines

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …

News

Novelos abandons candidate in lung cancer

March 20, 2010
Research and Development NSCLC, breast cancer

 

News

Baxter Alzheimer’s candidate shows promise

March 20, 2010
Research and Development Alzheimer's, baxter

Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …

News

GSK’s Relovair moves into phase III

March 19, 2010
Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory

GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …

News

European approval for ‘double strength’ Faslodex

March 19, 2010
Sales and Marketing AstraZeneca, Faslodex, breast cancer

AstraZeneca’s Faslodex has expanded its European licence after winning approval to treat women with hormone receptor-positive breast cancer in a …

News

Cephalon to develop new class of cancer drug

March 19, 2010
Research and Development CRT, Cancer, Cancer Research UK, Cephalon

Pennsylvania-based Cephalon has signed a deal with the discovery arm of charity Cancer Research UK to develop a new class …

News

LEC appoints Matthew Baker

March 19, 2010
Medical Communications Lane Earl Cox, appointment, medical communications

UK healthcare advertising agency Lane Earl Cox (LEC) has appointed Matthew Baker as deputy managing director. He joins LEC from …

Appointment

Brandcast strengthens healthcare team

March 19, 2010
Medical Communications Brandcast, appointment, medical communications

Digital agency Brandcast Media has added two new members to its London-based team. Lily Max (pictured left) joins as video …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025